Viewing Study NCT01303692


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2025-12-26 @ 9:37 AM
Study NCT ID: NCT01303692
Status: COMPLETED
Last Update Posted: 2015-01-14
First Post: 2011-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module